Investigation Reveals Public Health Risks from Illicit Experimental Weight Loss Drug

A CBS News investigation found that products marketed as retatrutide, an experimental weight-loss drug not approved by the FDA, are readily available online and in stores without medical oversight. Lab tests of these illicit products yielded concerning results, highlighting significant public health risks. This follows earlier reports to the FDA of two potential deaths linked to black-market retatrutide, underscoring the dangers of unregulated pharmaceutical access.